Literature DB >> 17044957

Trends, perinatal characteristics, and medical conditions in pervasive developmental disorders.

Pascale Guillem1, Christine Cans, Vincent Guinchat, Marc Ratel, Pierre-Simon Jouk.   

Abstract

Our aim was to study trends in the prevalence of pervasive developmental disorders (PDD) and to quantify their association with morphogenetic anomalies and with perinatal characteristics such as gestational age, birthweight, and hospitalization in a neonatal care unit. Data from a French morbidity register of childhood disabilities with the use of consistent definitions over time within the same geographical area were analyzed. The data of a total of 454 children (312 males, 142 females) with PDD, born between 1980 and 1993 and residing in Isère county, were recorded at the age of 7 years. The overall prevalence of PDD was 22.2 out of every 10000. There was a significant increase, from 14.7 to 30.8 out of every 10 000, during the period of study. Among these children with PDD, morphogenetic anomalies were observed in 12.1% (95% confidence interval [CI] 9.3-15.5), and the hospitalization rate during the neonatal period was 22% (95% CI 17.0-27.5), which is significantly higher than the observed rates in the general population. The increase in the prevalence of PDD, the association with perinatal risk factors, and the high rate of neonatal hospitalization require further studies to investigate the reasons for and mechanisms of these developmental disorders.

Entities:  

Mesh:

Year:  2006        PMID: 17044957     DOI: 10.1017/S0012162206001964

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  8 in total

1.  Have secular changes in perinatal risk factors contributed to the recent autism prevalence increase? Development and application of a mathematical assessment model.

Authors:  Laura A Schieve; Catherine Rice; Owen Devine; Matthew J Maenner; Li-Ching Lee; Robert Fitzgerald; Martha S Wingate; Diana Schendel; Sydney Pettygrove; Kim van Naarden Braun; Maureen Durkin
Journal:  Ann Epidemiol       Date:  2011-10-13       Impact factor: 3.797

Review 2.  Prenatal risk factors for autism: comprehensive meta-analysis.

Authors:  Hannah Gardener; Donna Spiegelman; Stephen L Buka
Journal:  Br J Psychiatry       Date:  2009-07       Impact factor: 9.319

Review 3.  Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis.

Authors:  Hannah Gardener; Donna Spiegelman; Stephen L Buka
Journal:  Pediatrics       Date:  2011-07-11       Impact factor: 7.124

4.  Low but increasing prevalence of autism spectrum disorders in a French area from register-based data.

Authors:  Marit Maria Elisabeth van Bakel; Malika Delobel-Ayoub; Christine Cans; Brigitte Assouline; Pierre-Simon Jouk; Jean-Philippe Raynaud; Catherine Arnaud
Journal:  J Autism Dev Disord       Date:  2015-10

5.  The association between autism spectrum disorders and congenital anomalies by organ systems in a Finnish national birth cohort.

Authors:  Laura Timonen-Soivio; Andre Sourander; Heli Malm; Susanna Hinkka-Yli-Salomäki; Mika Gissler; Alan Brown; Raija Vanhala
Journal:  J Autism Dev Disord       Date:  2015-10

6.  Congenital malformation and autism spectrum disorder: Insight from a rat model of autism spectrum disorder.

Authors:  Rakesh K Ruhela; Phulen Sarma; Shringika Soni; Ajay Prakash; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2017 May-Jun       Impact factor: 1.200

7.  The association between congenital anomalies and autism spectrum disorders in a Finnish national birth cohort.

Authors:  Laura Timonen-Soivio; Raija Vanhala; Heli Malm; Susanna Leivonen; Elina Jokiranta; Susanna Hinkka-Yli-Salomäki; Mika Gissler; Alan S Brown; Andre Sourander
Journal:  Dev Med Child Neurol       Date:  2014-09-08       Impact factor: 5.449

8.  Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk?

Authors:  Claire Amiet; Isabelle Gourfinkel-An; Claudine Laurent; Nicolas Bodeau; Bérengère Génin; Eric Leguern; Sylvie Tordjman; David Cohen
Journal:  Mol Autism       Date:  2013-12-01       Impact factor: 7.509

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.